1. FDA Approves CAR-T Cell Therapy to Treat Adults with Certain Types of Large B-Cell Lymphoma;U.S. Food and Drug Administration,2017
2. U.S. Food and Drug Administration. KYMRIAH (tisagenlecleucel). 2018, 05/07/18, July 31, 2018; Available from: https://www.fda.gov/BiologicsBloodVaccines/CellularGeneTherapyProducts/ApprovedProducts/ucm573706.htm.
3. Safety of retroviral vectors: regulatory and technical considerations;Cornetta,2008
4. Biosafety features of lentiviral vectors;Schambach;Hum Gene Ther,2013
5. Retrovirus packaging cells;Miller;Hum Gene Ther,1990